
Retatrutide in 2026: What Patients Researching Triple-Agonist Weight Loss Should Know Before They Ask a Doctor
There’s a drug racking up better weight-loss numbers than almost anything before it, and it’s still not sitting on a single U.S. pharmacy shelf. If







